| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
3e-23 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.3 |
6e-22 |
| mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.24 |
4e-16 |
| mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.24 |
3e-14 |
| mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
4e-13 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
8e-13 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
1e-12 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-12 |
| mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
7e-12 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
1e-11 |